What makes s pyogenes so virulent

Genomic data reported here have shed some light on the outbreaks caused by S. While four strains have virulence factors content highly similar to the MGAS strain, the Sp2 isolate has different genomic organization and virulence factors composition. This suggests the emergence of new S. The MGAS strain is invasive and dispersed worldwide, and this was the first time that a like outbreak is genetically characterized in South America. Additionally, the great capacity for dispersal of this aggressive bacterium is a serious public health issue.

The stress caused by the unselective usage of antimicrobial drugs, which is very common in Brazil, could have led to the rapid evolution and adaptation of this pathogen. This protein can be used as marker to identify these modern like infections. The genome sequence can be used to develop specific drugs to control the infections. In summary, an improvement in surveillance systems is extremely urgent, so that outbreaks of invasive S.

All authors designed the experiments, read and approved the final manuscript. The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. Al-ajmi, J. Group A Streptococcus toxic shock syndrome: an outbreak report and review of the literature. Public Health 5, — Alam, F. Alikhan, N. BMC Genomics Altschul, S.

Basic local alignment search tool. Andreassi, J. Streptococcus pneumoniae isoprenoid biosynthesis is downregulated by diphosphomevalonate: an antimicrobial target. Biochemistry 43, — Bankevich, A. SPAdes: a new genome assembly algorithm and its applications to single-cell sequencing.

Besemer, J. GeneMark: web software for gene finding in prokaryotes, eukaryotes and viruses. Nucleic Acids Res. Bisno, A. Molecular basis of group A streptococcal virulence. Lancet Infect. Bolger, A. Trimmomatic: a flexible trimmer for Illumina sequence data. Bioinformatics 30, — Bolotin, A. Complete sequence and comparative genome analysis of the dairy bacterium Streptococcus thermophilus.

Carapetis, J. The global burden of group A streptococcal diseases. Chen, L. VFDB: a reference database for bacterial virulence factors. Clarke, J. Cold Spring Harb.

Clarke, S. Analysis of Ebh, a 1. Courtney, H. Anti-phagocytic mechanisms of Streptococcus pyogenes : binding of fibrinogen to M-related protein. Darling, A. Davis, B. A satellite phage-encoded antirepressor induces repressor aggregation and cholera toxin gene transfer. EMBO J. Fernandes, G. PubMed Abstract Google Scholar. Ferretti, J. Complete genome sequence of an M1 strain of Streptococcus pyogenes.

Flock, J. Extracellular-matrix-binding proteins as targets for the prevention of Staphylococcus aureus infections. Today 5, — Graham, M. Virulence control in group A Streptococcus by a two-component gene regulatory system: global expression profiling and in vivo infection modeling. Gurevich, A.

QUAST: quality assessment tool for genome assemblies. Bioinformatics 29, — Hause, L. Nucleotides critical for the interaction of the Streptococcus pyogenes Mga virulence regulator with Mga-regulated promoter sequences. Hondorp, E. Characterization of the Group A Streptococcus Mga virulence regulator reveals a role for the C-terminal region in oligomerization and transcriptional activation.

Jolley, K. BIGSdb: scalable analysis of bacterial genome variation at the population level. BMC Bioinformatics Jordan, I. Essential genes are more evolutionarily conserved than are nonessential genes in bacteria. Genome Res. Kang, H. Crystal structure of Spy, a Streptococcus pyogenes class B sortase involved in pilus assembly.

Kreikemeyer, B. The intracellular status of Streptococcus pyogenes : role of extracellular matrix-binding proteins and their regulation. Kwinn, L. Li, L. OrthoMCL: identification of ortholog groups for eukaryotic genomes. Lofling, J. Cellular interactions by LPxTG-anchored pneumococcal adhesins and their streptococcal homologues.

Cell Microbiol. Loughman, J. A novel adaptation of aldolase regulates virulence in Streptococcus pyogenes. Maamary, P. Tracing the evolutionary history of the pandemic group A streptococcal M1T1 clone. Maguire, B. The roles of proteins L28 and L33 in the assembly and function of Escherichia coli ribosomes in vivo. Sub-MICs ie, concentrations one fourth of the MIC of linezolid, tetracycline, and chloramphenicol increased virulence factors activity in vitro in a similar fashion to CLI.

Our results go along with the findings by Tanaka et al [ 9 ]. In contrast, a reduction of virulence factors activity with sub-MICs of linezolid was described in GAS serotype M3 grown to stationary growth phase [ 39 ], as was the case for tigecycline and gentamicin. Thus, it may be considered an alternative option for treating severe invasive GAS infections, although nephrotoxicity and ototoxicity are feared complications.

We are the first to show in a comprehensive in vivo analysis that the addition of high doses of CLI, even in the presence of CLI-resistant GAS strains, resulted in improved clinical outcome.

These clinical benefits were directly linked to reduced virulence factors activity and therefore illustrate the important implications for the clinical use of CLI. In conclusion, CLI treatment proved to be beneficial for the reduction of disease severity and virulence factors activity in vivo. On the other hand, exposure to subinhibitory CLI concentrations in vitro increased virulence factors activity and abolished SpeB activity in CLI-susceptible and CLI-resistant GAS strains, possibly leading to increased virulence and a substantial survival advantage in the host [ 20 ].

This increase in virulence factors activity under subinhibitory CLI concentrations illustrates the importance of using CLI doses that are high enough.

It may give an explanation for disease progression despite antibiotic therapy and underlines the importance of aggressive surgical debridement for halting the disease, as recommended in the guidelines [ 1 ].

Our data indicate that, in addition to surgical debridement, CLI should be administered as soon as and at the highest dose possible to reach CLI levels above the MIC in affected tissues.

Financial support. Potential conflicts of interest. All authors: No reported conflicts. Conflicts that the editors consider relevant to the content of the manuscript have been disclosed. Practice guidelines for the diagnosis and management of skin and soft tissue infections: update by the Infectious Diseases Society of America. Clin Infect Dis ; 59 : e10 — Google Scholar. The Eagle effect revisited: efficacy of clindamycin, erythromycin, and penicillin in the treatment of streptococcal myositis.

J Infect Dis ; : 23 — 8. Comparative effects of clindamycin and ampicillin on superantigenic activity of Streptococcus pyogenes. J Antimicrob Chemother ; 40 : — 7.

Evidence for the presence of streptococcal-superantigen-neutralizing antibodies in normal polyspecific immunoglobulin G. Infect Immun ; 64 : — 8. Clinical efficacy of polyspecific intravenous immunoglobulin therapy in patients with streptococcal toxic shock syndrome: a comparative observational study.

Clin Infect Dis ; 59 : — 7. Effectiveness of clindamycin and intravenous immunoglobulin, and risk of disease in contacts, in invasive group a streptococcal infections. Clin Infect Dis ; 59 : — Necrotizing fasciitis: risk factors of mortality.

Risk Manag Healthc Policy ; 8 : 1 — 7. Toxic shock syndrome and bacterial superantigens: an update. Annu Rev Microbiol ; 55 : 77 — Effect of antibiotics on group A Streptococcus exoprotein production analyzed by two-dimensional gel electrophoresis. Antimicrob Agents Chemother ; 49 : 88 — Growth phase-dependent effect of clindamycin on production of exoproteins by Streptococcus pyogenes. Antimicrob Agents Chemother ; 51 : — 7. Clindamycin-induced CovS-mediated regulation of the production of virulent exoproteins streptolysin O, NAD glycohydrolase, and streptokinase in Streptococcus pyogenes.

Antimicrob Agents Chemother ; 54 : 98 — Influences of linezolid, penicillin, and clindamycin, alone and in combination, on streptococcal pyrogenic exotoxin a release.

Antimicrob Agents Chemother ; 47 : — 5. Clindamycin resistant emm33 Streptococcus pyogenes emerged among invasive infections in Helsinki metropolitan area, Finland, to Euro Surveill ; 20 : pii Emergence of erythromycin- and clindamycin-resistant Streptococcus pyogenes emm 90 strains in Hawaii.

J Clin Microbiol ; 49 : — Resistance of Streptococcus pyogenes to erythromycin and related antibiotics in Italy. Clin Infect Dis ; 27 suppl 1 : S87 — The SpeB virulence factor of Streptococcus pyogenes , a multifunctional secreted and cell surface molecule with strepadhesin, laminin-binding and cysteine protease activity.

Mol Microbiol ; 39 : — 9. Hyaluronic acid capsule is a virulence factor for mucoid group A streptococci. Cunningham MW. Pathogenesis of group A streptococcal infections. Clin Microbiol Rev ; 13 : — Cell Host Microbe ; 4 : — 8. DNase Sda1 provides selection pressure for a switch to invasive group A streptococcal infection. Nat Med ; 13 : — 5. Dissection of the molecular basis for hypervirulence of an in vivo-selected phenotype of the widely disseminated M1T1 strain of group A Streptococcus bacteria.

J Infect Dis ; : — Genetic relatedness and superantigen expression in group A streptococcus serotype M1 isolates from patients with severe and nonsevere invasive diseases.

Infect Immun ; 68 : — Invasive M1T1 group A Streptococcus undergoes a phase-shift in vivo to prevent proteolytic degradation of multiple virulence factors by SpeB. Mol Microbiol ; 51 : — Genome-wide analysis of group a streptococci reveals a mutation that modulates global phenotype and disease specificity. Plos Pathog ; 2 : e5. Agar and broth dilution methods to determine the minimal inhibitory concentration MIC of antimicrobial substances.

Nat Protoc ; 3 : — Streptolysin O and adherence synergistically modulate proinflammatory responses of keratinocytes to group A streptococci. Mol Microbiol ; 27 : — DNase expression allows the pathogen group A Streptococcus to escape killing in neutrophil extracellular traps. Curr Biol ; 16 : — Increased neutrophil extracellular trap-mediated Staphylococcus aureus clearance through inhibition of nuclease activity by clindamycin and immunoglobulin. PLoS One ; 8 : e Genetic switch to hypervirulence reduces colonization phenotypes of the globally disseminated group A streptococcus M1T1 clone.

J Infect Dis ; : 11 — 9. Highly frequent mutations in negative regulators of multiple virulence genes in group A streptococcal toxic shock syndrome isolates.

Plos Pathog ; 6 : e Failure of clindamycin to eradicate infection with beta-hemolytic streptococci inducibly resistant to clindamycin in an animal model and in human infections. Antimicrob Agents Chemother ; 58 : — Effects of linezolid on suppressing in vivo production of staphylococcal toxins and improving survival outcomes in a rabbit model of methicillin-resistant Staphylococcus aureus necrotizing pneumonia.

J Infect Dis ; : 75 — In our previous study, we found mutations in negative regulators that led to overproduction of a number of virulence factors 3. The mutation in the sic promoter is different in that only one protein the virulence factor SIC was probably overexpressed and this mutation led to the overexpression of SIC, implicating it as a crucial factor to STSS pathogenesis in vivo.

Thus, we speculate that emm1 isolates with this mutation are poised to be extremely virulent due to overexpression of this unique factor. However, as the consensus sequence is not disrupted by the insertion, we do not know if CsrR binding was affected. Perez et al. The sic gene may also be regulated by other small RNAs Structural changes in the RNA binding site of sic may have occurred due to the 6-bp insertion and the small RNAs would not be able to bind, perhaps leading to upregulation of sic.

Recently, Rosinski-Chupin et al. It is also well established that promoters with a bp spacer yield higher levels of transcription than otherwise identical promoters with bp spacers 19 , 20 , These studies further corroborate our findings that decrease of csrR gene transcription observed in emm1 isolates was due to shorter spacer length.

The frequency of mutation in the rocA gene was not significant between STSS and non-invasive isolates. Lynskey et al. In this study, RocA in an emm18 isolate and many emm3 isolates were truncated at the same position in both STSS isolates and non-invasive isolates. RocA in an emm11 isolate and an emm81 isolate was also truncated at the same position. While rocA mutations in emm1 isolates may not have been significantly observed at a higher frequency in STSS vs.

In conclusion, we have identified novel mutations that increased virulence gene s expression in STSS emm1 isolates, specifically the sic promoter or the rocA gene. These mutations caused lethality in mice and the significantly higher frequency of the sic promoter mutation in STSS emm1 isolates implicates this mutation of utmost importance in the landscape of STSS onset and pathogenesis.

This study complies with the guidelines of the declaration of Helsinki. This study protocol was approved by the institutional individual ethics committees for the use of human subjects the National Institute of Infectious Diseases Ethic Review Board for Human Subjects and the animal experiments the National Institute of Infectious Diseases Animal Experiments Committee. Written informed consent was obtained from study participants. All clinical samples were stripped of personal identifiers not necessary for this study.

All animal experiments were performed according to the Guide for animal experiments performed at National Institute of Infectious Diseases, Japan. The plasmids used in this study are described in Table 2. Nucleotide sequences were determined using automated sequencers, such as the Applied Biosystems xl Genetic Analyzer Applied Biosystems, Tokyo, Japan. To construct plasmids that could measure sic transcriptional levels, we used the pABG5 plasmid 23 that has the phoZF reporter gene.

When expressed, this reporter gene will produce alkaline phosphatase that is secreted from cells and can easily be measured. The replacement of the native rocA gene by the rocA -deleted mutant allele was verified by PCR and the resultant strain was named SerocA.

This plasmid was then introduced into the non-STSS strain Se by electroporation and transformants were selected as described above. The reporter gene phoZF used in this study encodes a chimeric protein consisting of both the N-terminal domain of protein F and the C-terminal domain of Enterococcus faecalis alkaline phosphatase phoZ.

PhoZF is secreted from the cell and detected in the supernatant. Alkaline phosphatase activity was measured as previously described To examine the expression of virulence genes in emm1 -genotyped isolates, total RNA was extracted from 44 emm1 -genotyped STSS isolates and 3 emm1 -genotyped non-invasive isolates negative controls and we performed quantitative RT-PCR to assess the transcriptional abundance of five virulence genes, scpA, sic, sda1, nga and ska , known to be elevated in invasive strains 4.

Measurements were performed in triplicate; a reverse-transcription-negative blank of each sample and a no-template blank served as negative controls. Primers and probes were described Supplementary Table 1. The reference genome sequence used was S. The number of mice that survived was compared statistically using the Kaplan-Meier log-rank test.

How to cite this article : Ikebe, T. Spontaneous mutations in Streptococcus pyogenes isolates from streptococcal toxic shock syndrome patients play roles in virulence. Cunningham, M. Pathogenesis of group A streptococcal infections. Bisno, A. Streptococcal infections of skin and soft tissues.

Ikebe, T. Highly frequent mutations in negative regulators of multiple virulence genes in group A streptococcal toxic shock syndrome isolates. PLos Pathog. Article Google Scholar. Sumby, P. Genome-wide analysis of group a streptococci reveals a mutation that modulates global phenotype and disease specificity.

Gusa, A. Cole, J. Molecular insight into invasive group A streptococcal disease. Hartas, J. Streptococcus pyogenes strains containing emm12 and emm55 possess a novel gene coding for distantly related SIC protein. Lynskey, N. Miller, E. Regulatory rewiring confers serotype-specific hyper-virulence in the human pathogen group A Streptococcus. Akesson, P.

Protein SIC, a novel extracellular protein of Streptococcus pyogenes interfering with complement function. Fernie-King, B. Streptococcal inhibitor of complement inhibits two additional components of the mucosal innate immune system: secretory leukocyte proteinase inhibitor and lysozyme.

Frick, I. SIC, a secreted protein of Streptococcus pyogenes that inactivates antibacterial peptides. Binks, M. Genomic location and variation of the gene for CRS, a complement binding protein in the M57 strains of Streptococcus pyogenes. Increased prevalence of group A streptococcus isolates in streptococcal toxic shock syndrome cases in Japan from — Federle, M.

Identification of binding sites for the group A streptococcal global regulator CovR. Perez, N. PLos ONE 4, e Mangold, M.

Synthesis of group A streptococcal virulence factors is controlled by a regulatory RNA molecule. Rosinski-Chupin, I. Single nucleotide resolution RNA-seq uncovers new regulatory mechanisms in the opportunistic pathogen Streptococcus agalactiae. BMC Genomics 16, Aoyama, T.